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ABSTRACT Alamethicin is a 20-residue, hydrophobic, helical peptide, which forms voltage-sensitive ion channels in lipid
membranes. The helicogenic, nitroxyl amino acid TOAC was substituted isosterically for Aib at residue positions 1, 8, or 16 in
a F50/5 alamethicin analog to enable EPR studies. Electron spin-echo envelope modulation (ESEEM) spectroscopy was
used to investigate the water exposure of TOAC-alamethicin introduced into membranes of saturated or unsaturated diacyl phos-
phatidylcholines that were dispersed in D2O. Echo-detected EPR spectra were used to assess the degree of assembly of the
peptide in the membrane, via the instantaneous diffusion from intermolecular spin-spin interactions. The proﬁle of residue expo-
sure to water differs between membranes of saturated and unsaturated lipids. In monounsaturated dioleoyl phosphatidylcholine,
D2O-ESEEM intensities decrease from TOAC
1 to TOAC8 and TOAC16 but not uniformly. This is consistent with a transmembrane
orientation for the protoassembled state, in which TOAC16 is located in the bilayer leaﬂet opposite to that of TOAC1 and TOAC8.
Relative to the monomer in ﬂuid bilayers, assembled alamethicin is disposed asymmetrically about the bilayer midplane. In satu-
rated dimyristoyl phosphatidylcholine, the D2O-ESEEM intensity is greatest for TOAC
8, indicating a more superﬁcial location for
alamethicin, which correlates with the difference in orientation between gel- and ﬂuid-phase membranes found by conventional
EPR of TOAC-alamethicin in aligned phosphatidylcholine bilayers. Increasing alamethicin/lipid ratio in saturated phosphatidyl-
choline shifts the proﬁle of water exposure toward that with unsaturated lipid, consistent with proposals of a critical concentration
for switching between the two different membrane-associated states.
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Alamethicin is a hydrophobic a-helical peptaibol that induces
voltage-dependent ion channels in lipid membranes (1,2).
There are two variants that have either a glutamic acid or
a glutamine residue at position 18. The latter variant, alame-
thicin F50/5, bears no electrical charge and is used here as
the [Glu(OMe)7,18,19] analog. Substitution of an Aib residue
at position 1, 8, or 16 by the equally helicogenic nitroxyl
amino acid TOAC (3–5) produces a spin-labeled analog
that can be used to investigate the membrane environment
of alamethicin F50/5 by means of EPR spectroscopy. Crystal
structure determination by x-ray diffraction shows that
TOAC-substituted [Glu(OMe)7,18,19] alamethicin F50/5 has
a kinked helical configuration that is very similar to that of
native alamethicin, and functional studies show ion-channel
activity of this alamethicin analog in membranes (6).
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0006-3495/09/02/0997/11 $2.00Previous studies have shown that alamethicin is predomi-
nantly monomeric in fluid lipid membranes, in the absence
of a membrane potential (7), and this has been found to be
the case also for the TOAC-labeled analogs (8,9). In the latter
case, the isotropic hyperfine couplings, measured by means of
CW-EPR, were used to establish the transmembrane orienta-
tion of TOAC-labeled alamethicin in phosphatidylcholine
bilayers. This is done by using calibrations with spin-labeled
phospholipids in fluid membranes (10,11). In the low-temper-
ature gel phase, the peptide tends to aggregate, even in the
absence of a membrane potential (8), which correlates with
the large increase in ion channel formation in the gel phase
(12). Recently, librational motions of the peptide backbone
on a timescale that is kinetically competent to participate in
ion conductance have been shown by pulsed EPR (13).
In this study, we use electron spin-echo spectroscopy to
study the association of water with TOAC-labeled
[Glu(OMe)7,18,19] alamethicin F50/5 in the low-temperature
state of phospholipid membranes with either fully saturated
(myristoyl) or monounsaturated (oleoyl) chains. (Note that
DMPC and DOPC have similar bilayer thicknesses at the
same temperature in the fluid phase (14,15)). Echo-detected
spectra are used to assess the degree of aggregation/assembly
of the peptide, from the instantaneous diffusion induced by
intermolecular spin-spin interactions. Electron spin-echo
envelope modulation (ESEEM) by D2O is used to study the
localization and interaction of water relative to the peptide
(16). Water penetration into phospholipid membranes has
been characterized previously by this technique (17,18), and
doi: 10.1016/j.bpj.2008.10.024
998 Bartucci et al.also the accessibility of water to spin-labeled lipids in the
binding sites of serum albumin has been investigated (19).
The 2H-ESEEM spectra of D2O are characterized by a broad
component that corresponds to water molecules that are
directly hydrogen-bonded to the spin-label nitroxide group,
and a sharp component that corresponds to water molecules
that are in the vicinity but located less closely to the nitroxide
(18). For peptides that are not aggregated, these latter
measurements may be used as a calibration to determine the
position of the spin-labeled peptide in lipid membranes
(20). Comparison with measurements in the fluid phase then
establishes the effects of peptide assembly on the water acces-
sibility. Because it has been found previously that alamethicin
can adopt two different membrane-associated configurations,
which depend not only on peptide/lipid ratio but also on the
particular lipid and the temperature (21–23), we also examine




Phospholipids, DMPC, DPPC, DOPC, and POPC, were from Avanti Polar
Lipids (Alabaster, AL). Spin-labeled derivatives of alamethicin F50/5,
[TOACm, Glu(OMe)7,18,19] with m ¼ 1, 8, and 16, which were synthesized
according to Peggion et al. (24,25), were kindly supplied by Prof. C. Toniolo
and M. de Zotti of the University of Padua. The complete amino-acid







where Aib is a-aminoisobutyric acid and Fol is L-phenylalaninol. These
TOAC-labeled alamethicin analogs are abbreviated here as TOACm-Alm.
The crystal structure of TOAC16-Alm shows a conformation very similar
to that of native alamethicin, and electrophysiological experiments show
functional ion channel activity for this TOAC-alamethicin analog (6).
Sample preparation
Phosphatidylcholine and the required mole ratio of TOAC spin-labeled ala-
methicin (in MeOH) were codissolved in CHCl3, and the solution was then
evaporated with dry nitrogen. (Note that the oligomeric state of alamethicin
depends on solvent polarity (26).) After keeping under vacuum overnight,
the dry mixture was dispersed at a concentration of ~100 mg/ml in D2O
by vortex mixing while heating to above the chain-melting transition of
the phosphatidylcholine. The hydrated lipid bilayers were transferred to
a standard 4 mm-diameter, quartz EPR tube, concentrated by pelleting in
a bench-top centrifuge, and the excess water was removed. The samples
were then incubated overnight at 4C. Immediately before pulse-EPR
measurements, the samples were frozen rapidly in liquid nitrogen and then
transferred to the spectrometer that was pre-equilibrated at 77 K. This
protocol should result in trapping of the DMPC samples in the gel phase,
and of the DOPC samples in a (metastable) disordered state.
Aligned planar phospholipid membranes were formed by evaporating
a CH2Cl2 solution of phospholipid plus 1 mol% of TOAC
8-Alm onto the
internal surfaces of a quartz flat cell (60  10 mm, with 0.3 mm spacing)Biophysical Journal 96(3) 997–1007by using a stream of dry nitrogen. Residual solvent was removed under
vacuum overnight. The oriented lipid film was hydrated with excess buffer
containing 150 mM NaCl. The cells were drained and sealed immediately
before measurement, retaining sufficient buffer to ensure complete hydration
throughout the measurement.
EPR spectroscopy
Pulsed EPR data were collected at 77 K on an ELEXSYS E580 9-GHz Four-
ier Transform FT-EPR spectrometer (Bruker Biospin, Rheinstetten,
Germany) equipped with an MD5 dielectric resonator and a CF 935P cryo-
stat (Oxford Instruments, UK). To obtain ESEEM spectra, three-pulse,
stimulated echo (p/2-t-p/2-T-p/2-t-echo) decays were collected by using
microwave pulse widths of 12 ns, with the microwave power adjusted to
give p/2-pulses. The time delay T between the second and the third pulses
was incremented from To ¼ 20 ns by N ¼ 700 steps of DT ¼ 12 ns, while
maintaining the separation t between the first and the second pulses constant
at 168 ns. A four-step phase-cycling program, þ(x,x,x), (x,x,x),
(x,x,x), þ(x,x,x), where the initial sign indicates the phase of the
detection (5y), was used to eliminate unwanted echoes.
The time-dependent echo amplitudes, V(t,T), were processed to yield
standardized ESEEM intensities, according to the protocol developed previ-
ously (18). The average experimental echo decay, <V(t,T)>, was obtained
by fitting V(t,T) versus T with a bi-exponential function. The normalized
ESEEM signal was then obtained as:
Vnormðt; TÞ ¼ Vðt; TÞ=hVðt; TÞi  1: (1)





Vnormðt; To þ jDTÞ
 expð  iukð2t þ To þ jDTÞÞ;
(2)
where uk ¼ 2pk/(NDT) with k ¼ N/2 to þN/2. The real and imaginary
Fourier coefficients are then used to obtain the absolute-value ESEEM
spectrum. Note that the discrete Fourier-transform software supplied with
the ELEXSYS FT-EPR spectrometer does not take account of different
dwell times, DT, in determining amplitudes of the ESEEM spectrum. Defi-
nition according to Eq. 2 provides machine-independent spectral densities,
with the dimensions of time, which can be used for comparing different
D2O-containing systems.
Calibration of the local water concentration at different depths in the
membrane is taken from D2O-ESEEM measurements with phospholipids
spin-labeled at different C-atom positions in the acyl chain, which are re-
ported in Erilov et al. (18). A multiplicative factor of 12 ns is required
to convert the intensities reported in the latter reference to absolute values
consistent with Eq. 2. Otherwise, ESEEM intensities should be obtained
from three-pulse echo decays recorded with increments in the time delay
DT ¼ 12 ns (together with t ¼ 168 ns, To ¼ 20 ns), which were used in Eri-
lov et al. (18) for recording the D2O-ESEEM calibration spectra, or be scaled
to this value of DT according to Eq. 2 from the dwell time actually used. For
instance, the ESEEM amplitudes in Salnikov et al. (20) should be multiplied
by a factor of 16/12 ¼ 1.333 to be compatible with the calibration data of
Erilov et al. (18) from spin-labeled lipids.
Conventional CW-EPR spectra were recorded either on an ESP-300
spectrometer (Bruker) or on a Varian Century-Line spectrometer (Varian,
Palo Alto, CA), both operating at 9 GHz with 100-kHz field modulation.
CW-spectra from aligned bilayers were obtained with quartz flat cells in
a TE102 rectangular microwave cavity mounted with the H1-field horizontal.
Either spectra were recorded at room temperature (20C), or the entire cavity
system was thermostated with nitrogen gas-flow.
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Aligned membranes
Fig. 1 shows the conventional CW-EPR spectra of the alame-
thicin analog that contains TOAC in the middle of the
peptide chain (TOAC8-Alm), in aligned multibilayers of
fully hydrated phosphatidylcholines in the gel and fluid
phases (lower and upper rows, respectively). Spectra are
shown for the static magnetic field parallel (solid lines) and
perpendicular (dashed lines) to the normal to the orienting
quartz substrate on which the multibilayers are deposited.
Although the alignment of the sample is probably not
completely homogeneous (as evidenced by apparent broad-
ening of the central line for the parallel orientation and outer
shoulders in the perpendicular orientation), there is clear
anisotropy between spectra recorded with the parallel and
perpendicular orientations of the magnetic field.
For DOPC and POPC bilayers in the fluid phase at 20C
(Fig. 1, a and b), the largest hyperfine splitting of the first
derivative-like single absorption lines is obtained in the
parallel orientation with the magnetic field lying along the
substrate normal (27). This shows that the director, N, for
the uniaxial rotational diffusion in the fluid phase lies along
the membrane normal. Because the principal z axis corre-
sponding to the largest hyperfine splitting of TOAC lies close
to the axis of ana-helix (28), the spectra from aligned samples
are consistent with a transmembrane orientation of the alame-
thicin molecule in fluid-phase DOPC and POPC. This conclu-
sion is also borne out by the spectra of the TOAC1-Alm and
TOAC16-Alm analogs in aligned membranes of DOPC and
POPC (data not shown).
For aligned DMPC in the gel phase at 12C (Fig. 1 c), the
largest hyperfine splitting is found with the magnetic field
directed perpendicular to the bilayer normal, and the line-shape for this orientation approximates that of a two-dimen-
sional powder pattern (29). This implies that the helical axis
of alamethicin lies preferentially parallel to the plane of the
membrane, when associated with gel-phase DMPC. The
situation is quite unlike the transmembrane orientation found
with fluid-phase phosphatidylcholines (Fig. 1, a and b, (8)).
Correspondingly, the smallest hyperfine splitting is found
with the magnetic field directed along the bilayer normal
in Fig. 1 c, although the overall lineshape for this orientation
evidences a considerable spread of disorder. For aligned
DPPC in the gel phase at 20C (Fig. 1 d), the spectra of
TOAC8-Alm are similar to those for gel-phase DMPC
(Fig. 1 c), indicating that alamethicin has the same
membrane orientation in the gel phases of the two saturated
lipids.
Note that the transmembrane orientation of alamethicin in
DOPC and POPC is a general feature of fluid-phase phospha-
tidylcholines and not a specific feature of 9,10 cis-unsatura-
tion, because a similar orientation is found when DMPC is
in the fluid phase (8).
ESEEM spectra
2H-ESEEM spectroscopy was used to investigate the degree
of accessibility to water of the TOAC residues, for alamethi-
cin in phospholipid bilayer membranes that are dispersed in
D2O (16). Fig. 2 shows absolute-value ESEEM spectra of
TOAC1-Alm, TOAC8-Alm, and TOAC16-Alm. The spin-
labeled alamethicin is incorporated either in DMPC bilayer
membranes, which have saturated chains, or in DOPC bilayer
membranes, which have unsaturated chains. The interpulse
separation, t, between the first and second pulses in the stim-
ulated echo sequence was set equal to 168 ns to maximize the
deuterium and proton modulations simultaneously.FIGURE 1 Conventional CW-EPR spectra of the
[TOAC8, Glu(OMe)7,18,19] alamethicin analog in aligned
phosphatidylcholine bilayers in the fluid (upper row) and
gel (lower row) phases. (Solid lines) magnetic field parallel
to the membrane normal; (dashed lines) magnetic field
perpendicular to the membrane normal. (a) in DOPC at
20C; (b) in POPC at 20C; (c) in DMPC at 12C; and
(d) in DPPC at 20C. Peptide/lipid ¼ 1:100 mol/mol. Total
scan width ¼ 100 Gauss.Biophysical Journal 96(3) 997–1007




FIGURE 2 Absolute-value Fourier-transform ESEEM spectra of [Glu(OMe)7,18,19] alamethicin F50/5 analogs with TOAC substituted for: (left column)
residue 1 (TOAC1-Alm), (center column) residue 8 (TOAC8-Alm), (right column) residue 16 (TOAC16-Alm), in: (a) DMPC bilayers at mole ratio 1:275;
(b) DMPC bilayers at 1:100 mol/mol; (c) DMPC bilayers at 1:20 mol/mol; and (d) DOPC bilayers at 1:100 mol/mol.Peaks are seen in the ESEEM spectra of TOAC1-Alm and
TOAC8-Alm (Fig. 2, left and center columns, respectively)
that are centered around the deuterium Larmor frequency
at ~2.6 MHz and around that of protons at 14.6 MHz. The
latter originates primarily from matrix protons. The ESEEM
spectra of TOAC16-Alm in DMPC (Fig. 2, right column) are
essentially devoid of intensity in the region of the 2H-Larmor
frequency, but have a spectral component at the proton
frequency that is similar in shape and amplitude to that of
TOAC1-Alm or TOAC8-Alm in DMPC. Water (i.e., D2O)
therefore is apparently absent at the location of the 16-
residue position of alamethicin with DMPC bilayers, even
at a peptide/lipid ratio of 1:20 mol/mol.
The 2H-ESEEM spectra of TOAC1-Alm and TOAC8-Alm
(Fig. 2, left and center columns) consist of a sharp doublet
superimposed on a much broader component. The sharp
doublet arises from free intramembranous D2O, and the broad
component arises from D2O that is hydrogen bonded to the
spin-label nitroxide group (18). Increasing the concentration
of the TOAC-labeled alamethicin from a peptide/DMPC ratio
of 1:275 mol/mol to 1:100 mol/mol decreases the normalized
2H-ESEEM intensity only slightly (compare Fig. 2, a and b).
Increasing the concentration further to a peptide/DMPC ratio
of 1:20 mol/mol (Fig. 2 c) produces a marked decrease in the
normalized 2H-ESEEM intensity. Under these conditions, theBiophysical Journal 96(3) 997–1007proton ESEEM intensity hardly changes, therefore suggesting
that the increased peptide concentration in saturated-chain
DMPC is accompanied by a decreased accessibility of
alamethicin to water.
The 2H-ESEEM spectra of TOAC1-Alm in DMPC (Fig. 2,
left column) differ quantitatively from those of TOAC8-Alm
(Fig. 2, center column). The overall intensity is lower and the
ratio of the broad to narrow 2H-ESEEM components is also
lower. These differences follow the trend seen also with
increasing concentration of the TOAC1 peptide. Evidently,
in saturated-chain DMPC, TOAC at residue position 1 has
a lower probability of hydrogen bonding to D2O than does
TOAC at residue position 8, although the local concentra-
tions of free D2O (narrow component) are more similar.
The 2H-ESEEM spectra of TOACm-Alm in unsaturated-
chain DOPC (Fig. 2 d) differ qualitatively from those in satu-
rated-chain DMPC at the same peptide/lipid ratio (Fig. 2 b).
The intensity decreases from TOAC1-Alm to TOAC8-Alm
and TOAC16-Alm in DOPC, whereas it is largest for
TOAC8-Alm in DMPC. To a certain extent, this mirrors the
change on increasing the peptide/lipid ratio from 1:100 to
1:20 mol/mol in DMPC, in that the 2H-ESEEM intensity of
TOAC1-Alm then becomes more comparable to that of
TOAC8-Alm. In general, the difference in exposure to D2O
between saturated and unsaturated phosphatidylcholines that
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orientation that is found between the phosphatidylcholine
gel and fluid phases, respectively, in aligned samples (Fig. 1).
Table 1 summarizes the normalized intensities of the total
and broad 2H-ESEEM components determined for the
different TOACm-Alm analogs in the two phosphatidylcho-
line lipid hosts. At low peptide concentration, the difference
between the hydration profiles of alamethicin in saturated
and unsaturated lipids is clearly evident. For DMPC, values
are given for samples with different peptide/lipid ratios.
These latter reflect the preferential decrease in 2H-ESEEM
intensities with increasing content of spin-labeled alamethi-
cin and the redistribution of relative intensities at high
concentrations in the saturated lipid.
CW-EPR powder spectra
The outer hyperfine splittings, 2Azz, in rigid-limit nitroxide
spectra depend on the local polarity (30). Fig. 3 shows the
conventional CW-EPR spectra of the three TOACm-Alm
spin-labeled peptides in DMPC or DOPC bilayer membranes
at 77 K. The peptide/lipid ratio is 1:100 mol/mol. Some inho-
mogeneous and/or spin-spin broadening is evident in these
spectra. (Note that the broadening may not be due entirely to
spin-spin interactions, because environmental microheteroge-
neity and conformational substates that are frozen-in can also
contribute substantially to Gaussian line widths in powder
spectra.) The rigid-limit values of the Azz-hyperfine coupling
deduced from these spectra are given in Table 2. To correct
for intrinsic differences between the residue positions, values
of Azz are referred to those of the same TOAC
m-Alm in meth-
anol. (Note that polarity-dependent contributions to hyperfine
couplings are additive (32,33).) The corrected values (DAzz)
differ for the three TOAC positions, indicating differences in
polarity of the local spin-label environment. However, the rela-
tive polarities in the saturated DMPC and DPPC lipids are not
in the same order as those reflected by the isotropic hyperfine
couplingsDao measured in the fluid phase at high temperature
((9), Fig. 4). The highest polarity is found for TOAC8-Alm in
TABLE 1 Normalized intensities of the total (Itot) and the broad
(Ibroad) components in the
2H-ESEEM spectra from TOACm-Alm
in D2O-lipid dispersions
Lipid/TOACm Peptide/lipid (mol/mol) Itot (ns) Ibroad (ns) Ibroad/Io*
DMPC/TOAC1 1:275 46 8 0.08
1:100 35 5 0.04
1:20 31 4 0.03
DMPC/TOAC8 1:275 54 14 0.13
1:100 49 12 0.11
1:20 36 6 0.05
DMPC/TOAC16 1:275,100,20 0 0 —
DOPC/TOAC1 1:100 83 23 0.20
DOPC/TOAC8 1:100 20 2 0.02
DOPC/TOAC16 1:100 19 1 0.01
*Io is the theoretical intensity for one D2O hydrogen bonded to the nitroxide
(18).DMPC. For the unsaturated DOPC lipid, on the other hand, the
values ofDAzz are closer to the order found forDao in fluid bila-
yers, which is TOAC1 > TOAC16 > TOAC8 for fluid-phase
phosphatidylcholines with chain lengths from C12 to C18
(9). In particular, TOAC8-Alm does not correspond to a higher
polarity than TOAC1-Alm. These sequences for DAzz also
correspond largely to the order of D2O-ESEEM intensities in
DOPC and DMPC (Table 1).
FIGURE 3 Conventional CW-EPR spectra of [Glu(OMe)7,18,19] alame-
thicin F50/5 analogs with TOAC substituted for: residue 1, TOAC1-Alm;
residue 8, TOAC8-Alm; and residue 16, TOAC16-Alm; in bilayers of
DMPC (upper of each pair) or DOPC (lower of each pair) at 77 K.
Peptide/lipid ¼ 1:100 mol/mol.
TABLE 2 Rigid-limit hyperﬁne couplings, Azz, of spin-labeled















DMPC 32.6 3.0 33.4 2.6 31.4 3.7
DPPC 33.0 2.6 34.1 1.9 32.8 2.3
DOPC 34.5 1.1 34.8 1.2 33.0 2.1
DAzz is referred to Azz in methanol, i.e.: DAzz ¼ Azz(PC)  Azz(MeOH).Biophysical Journal 96(3) 997–1007
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The isotropic hyperfine couplings, ao, of the TOAC
m-Alm
analogs have been determined at high temperatures in the
fluid phase of DMPC and DPPC bilayers, for which the
CW-spectra are in the fast motional regime (8,9). These
values should depend only on the polarity of the environ-
ment in which the spin label is situated (11,32). Fig. 4 gives
the isotropic couplings, Dao, relative to those measured in
methanol, to correct for intrinsic differences between the
three TOAC positions. For the purposes of calibration, the
dependence of ao on position in the sn-2 chain of spin-
labeled phosphatidylcholine, n-PCSL, is also included in
Fig. 4. These values are likewise given relative to those in
methanol, i.e., Dao ¼ ao(PC)  ao(MeOH), to correct for
FIGURE 4 Effective isotropic hyperfine couplings, ao, for
[Glu(OMe)7,18,19] alamethicin TOAC1, TOAC8, and TOAC16 analogs, as
indicated, in fluid-phase DMPC (solid horizontal lines) and fluid-phase
DPPC (dashed horizontal lines) bilayers (8,9). To establish the transmem-
brane location of the TOAC labels, the dependence of ao on nitroxide posi-
tion, n, in the sn-2 chain of spin-labeled phosphatidylcholine, n-PCSL, in
DMPC (circles) and DPPC (squares) fluid-phase bilayers is given by the
dotted lines (10). All values of ao are given relative to those in methanol,
i.e.: Dao ¼ ao(PC)  ao(MeOH), and are constant over a wide range of
temperature in the respective fluid phases. The relative order for Dao of
TOACm-Alm in fluid-phase phosphatidylcholines is: TOAC1 > TOAC16 >
TOAC8, for chain lengths C12–C18 (9).Biophysical Journal 96(3) 997–1007the intrinsic difference in isotropic couplings of DOXYL ni-
troxides (in n-PCSL) and TOAC nitroxides (34). Note that
the transbilayer polarity profile is not disturbed by the pres-
ence of a membrane-spanning a-helical peptide, WALP,
which is both hydrophobic and uncharged, as are the alame-
thicin analogs used here (35). Therefore, the transmembrane
profiles of the peptide-free bilayer are appropriate references
to determine the location of the TOACm-Alm analogs.
For all three TOAC positions of alamethicin in fluid
membranes, the effective isotropic hyperfine splitting
constants correspond to a lower polarity in DPPC bilayers
than in the thinner DMPC bilayers. In DMPC, the TOAC1
residue is situated in a more polar location than that of the 4
C-atom of the phosphatidylcholine sn-2 chain, but in the region
of the 4–6 C-atom in DPPC. The TOAC8 residue in DPPC,
is situated toward the center of the bilayer, in the region of the
10–14 C-atom of the lipid chains. In DMPC, TOAC8 is located
at a similar depth as the 8–9 C-atom of the chain. The TOAC16
residue is located close to the 8 C-atom of the lipid chains in
DPPC, and between the 7 and 8 C-atoms in DMPC. Clearly,
TOAC16 resides in the opposite bilayer leaflet from that of
TOAC8 and TOAC1, because the various crystal structures
(6,36) and solution NMR structure (37,38) show that alamethi-
cin adopts a predominantly extended helical conformation.
ED-EPR spectra
Echo-detected (ED)-EPR spectra are sensitive to spin-spin
interactions that cause so-called instantaneous (spin) diffu-
sion, even in the absence of molecular motion (39). This is
therefore a sensitive means to investigate aggregation or
cluster formation of spin-labeled peptides.
Fig. 5 shows the ED-EPR spectra of the TOACm-Alm
analogs in DMPC bilayers at different peptide/lipid ratios
and in DOPC bilayers at 1:100 mol/mol. The dependence of
the ED-lineshapes on echo delay-time at 77 K is characteristic
of instantaneous diffusion arising from spin-spin interactions.
For this process, the central region of the spectrum decays
faster with increasing t than do the outer wings (40). (Note
that the ED-spectra in Fig. 5 are normalized to the central
line height.) The ED-spectra of TOACm-Alm in DMPC are
rather similar at the two lower peptide/lipid ratios of 1:275
and 1:100 mol/mol, and show only limited instantaneous
diffusion. At the higher alamethicin/DMPC mole ratio of
1:20, instantaneous diffusion is much more rapid correspond-
ing to a greater degree of spin-spin interaction between
TOAC-labeled alamethicins.
Of decisive significance is the much higher instantaneous
diffusion at the TOAC1 position than at the TOAC8 and
TOAC16 positions (Fig. 5 c). In principle, the weaker spin-
spin interactions for the latter two positions could arise from
longer-range dipolar interactions between aggregates, which
should be the same at all TOAC spin-label positions.
However, the much stronger spin-spin interactions at the
TOAC1 position must be attributed to specific aggregate




FIGURE 5 Echo-detected EPR spectra of: (left column) residue 1 (TOAC1-Alm), (center column) TOAC8-Alm, and (right column) TOAC16-Alm, in:
(a) DMPC bilayers at 1:275 mol/mol; (b) DMPC bilayers at 1:100 mol/mol; (c) DMPC bilayers at 1:20 mol/mol; and (d) DOPC bilayers at 1:100 mol/mol.
ED-spectra are recorded for increasing interpulse spacings of (bottom to top) t ¼ 168, 296, 424, 552, 680, and 804 ns, and are normalized to the maximum
central line height. T ¼ 77 K.formation at an alamethicin/DMPC ratio of 1:20 mol/mol, in
which the TOAC1 labels are located closer to each other than
are the TOAC8 or TOAC16 labels. Evidently, TOACm-Alm is
predominantly monomeric at peptide/lipid ratios of 1:275 and
1:100 mol/mol in the DMPC preparations, but is appreciably
aggregated at the higher concentration of 1:20 mol/mol. A
possible reason for the preferential interaction at the residue
1 position in DMPC might be a tendency to head-to-head
association of the partially inserted peptide.
In DOPC at a peptide/lipid ratio of 1:100 mol/mol, all three
TOACm-Alm peptides show stronger spin-spin interactions
than in DMPC at 1:100 mol/mol, with the greatest extent
for TOAC1-Alm. Again, the discrimination between different
TOAC label positions is diagnostic for specific aggregation.
From this it can be concluded that TOACm-Alm has a greater
tendency to self-assemble in DOPC than in DMPC. In DOPC,
TOAC1 might be oriented preferentially toward the center of
a transmembrane helix bundle and hence experience greater
spin-spin interactions. Possibly, this may also apply in
DMPC at high peptide concentrations.
Table 3 lists values of C/L, the line height of the central
peak in the ED-spectra, relative to that at low-field, for
TOACm-Alm at different peptide/lipid ratios in the saturated
and unsaturated phosphatidylcholine lipid hosts. The C/L
line height ratio (41) is a sensitive monitor of instantaneousdiffusion. It decreases progressively with increasing echo
delay time t in an approximately exponential fashion (41),
and the rate of decay is a measure for the strength of spin-
spin interactions (cf. above). Thus, C/L decreases with
increasing peptide/lipid ratio, at all values of t. Furthermore,
it is greater for TOACm-Alm in DOPC than in DMPC at the
same peptide/lipid ratio (and same value of t).
TABLE 3 Central line height (C), normalized to that at low ﬁeld
(L), in the echo-detected EPR spectra from TOACm-Alm in
phosphatidylcholine membranes, for different delay times t
Lipid/TOACm Peptide/lipid (mol/mol)
C/L
t ¼ 168 ns t ¼ 804 ns
DMPC/TOAC1 1:275 1.76 1.52
1:100 1.58 1.20
1:20 1.21 0.58
DMPC/TOAC8 1:275 1.72 1.38
1:100 1.57 1.17
1:20 1.45 0.85
DMPC/TOAC16 1:275 1.52 1.24
1:100 1.56 1.34
1:20 1.21 0.71
DOPC/TOAC1 1:100 1.36 0.87
DOPC/TOAC8 1:100 1.31 1.11
DOPC/TOAC16 1:100 1.42 1.05Biophysical Journal 96(3) 997–1007
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Membrane topography of alamethicin
At low peptide contents, the D2O-ESEEM spectra show that
the pattern of alamethicin exposure to water differs qualita-
tively between membranes composed of saturated and unsat-
urated lipids (Table 1). In the unsaturated lipid (DOPC),
maximum water exposure is found for TOAC1-Alm at the
N-terminus, whereas in the saturated lipid (DMPC),
maximum water exposure is found for TOAC8-Alm toward
the middle of the peptide. A similar distinction is found in
the environmental polarities registered by the rigid-limit
hyperfine couplings (DAzz), which are largest for TOAC
1-
Alm in DOPC, and for TOAC8-Alm in DMPC (Table 2).
This distinction between unsaturated and saturated lipid
membranes in the frozen state parallels the difference in
membrane orientation of alamethicin that is found between
DOPC and POPC in the fluid phase, on the one hand, and
DMPC and DPPC in the gel phase, on the other hand, at
near-ambient temperatures (Fig. 1). In the fluid phase of
the unsaturated lipids, alamethicin adopts a transmembrane
orientation, parallel to the membrane normal, as found previ-
ously for the fluid phase of DMPC (8). In the gel phase of the
saturated lipids, however, alamethicin is oriented more
closely parallel to the membrane surface.
Huang and co-workers (42) have shown previously that
alamethicin can adopt two different states when bound to lipid
bilayer membranes: one in which the helix axis is oriented
parallel to the membrane surface, and the other in which the
helix orientation is transmembrane. The preferred orienta-
tional state is determined by a critical peptide/lipid ratio that
depends both on the particular lipid, and on the temperature
and degree of hydration (21–23). The EPR results presented
here with TOAC-alamethicin in aligned membranes (Fig. 1)
are in agreement with these conclusions. It is therefore
reasonable to suggest that the different hydration profiles
found here may also reflect different orientations of alamethi-
cin: parallel to the membrane surface in DMPC, and trans-
membrane in DOPC, at the low temperatures that are required
for the ESEEM experiments. Further support for this proposal
comes from the relative D2O-ESEEM intensities at higher
peptide/lipid ratio (1:20 mol/mol) in the saturated DMPC
lipid (Table 1). These exhibit a positional profile that is
much closer to that obtained with the unsaturated DOPC lipid
than is found at lower peptide/lipid ratios, suggesting that
the critical concentration for transmembrane insertion in satu-
rated lipids has been achieved at 1:20 mol/mol.
Hydration proﬁles
The echo-detected EPR spectra at 77 K indicate an
increasing degree of spin-spin interaction with increasing
concentration of TOAC-labeled alamethicin (Fig. 5). This
suggests that oligomerization of alamethicin partially takes
place at low temperature in the frozen state. It is thereforeBiophysical Journal 96(3) 997–1007of direct interest to compare the water accessibility in this
proto-assembled state with that in the fluid membrane state,
where it is known both from conventional CW-EPR and
from saturation transfer EPR that alamethicin is in a predom-
inantly monomeric state (7–9). This comparison is made here
below. Distinction must be made between ESEEM results
from unsaturated and saturated lipids because, as seen
already, the alamethicin configuration differs between these
two classes of host membrane.
Measurements of isotropic hyperfine couplings in fluid
membranes (Fig. 4) indicate clearly that TOAC-labeled
alamethicin adopts a transmembrane orientation in DMPC
and DPPC bilayers when they are above their respective
chain-melting transitions. This is also true of alamethicin
in fluid-phase phosphatidylcholine bilayers of other acyl
chain lengths (9). In fluid-phase DMPC, the N-terminal
TOAC1 residue resides in the lipid polar headgroup region
of the membrane, and the C-terminal phenylalaninol has
a similar location but at the opposite surface of the bilayer
(9). In fluid-phase DPPC, the N-terminal TOAC1 residue is
situated close to the polar-apolar interface of the membrane,
and the C-terminal phenylalaninol again has a similar loca-
tion at the opposite side of the membrane. Thus, in fluid
membranes of different thicknesses, alamethicin occupies
approximately the same position relative to the bilayer
mid-plane (9).
Fig. 6 gives the D2O-ESEEM amplitudes for the TOAC
m-
Alm analogs in bilayers of the unsaturated lipid DOPC (solid
lines) and of the saturated lipid DMPC (dashed lines). Cali-
bration ESEEM data from spin-labeled lipid chains, n-PCSL,
in DPPC bilayers are included for comparison. The latter
have been converted from the values reported originally
(18), according to the standardized procedure defined by
Eqs. 1 and 2. The D2O-ESEEM amplitude from the
N-terminal TOAC1 residue in DOPC correlates with the lipid
polar headgroup region of the membrane. The D2O-ESEEM
amplitudes for the TOAC8 and TOAC16 analogs in DOPC
are similar, indicating that these residues are situated at similar
locations on opposite sides of the bilayer midplane. The
amplitudes correlate approximately with the C12 atoms of
the lipid sn-2 chain, which are expected to have a separation
of 1.29 nm between the two bilayer leaflets in the gel phase
of DPPC, allowing for the terminal methyl groups and sn-1/
sn-2 chain mismatch (43) and a 35 chain tilt (44). This sepa-
ration is therefore sufficient to accommodate the distance
between TOAC8 and TOAC16 in a fully extended helix.
Comparing Figs. 4 and 6, it is thus seen that, for TOACm-
Alm analogs in frozen DOPC membranes, the TOAC1 and
TOAC8 residues correlate with positions similar, relative to
the lipid chains, to those found in fluid bilayers. The
TOAC16 residue, on the other hand, although situated in
the apposing bilayer leaflet, correlates with a position closer
to the bilayer midplane in the thicker frozen membranes of
DOPC than in fluid bilayers. This indicates a more asym-
metric location of alamethicin with respect to the membrane
Alamethicin Transmembrane Polarity 1005midplane in frozen DOPC membranes than in fluid bilayers.
The results on spin diffusion (Fig. 5 and Table 3) indicate
preferential self-assembly of TOACm-Alm in DOPC, relative
to DMPC. Therefore, the asymmetric offset within the
membrane may be a distinguishing feature of the protoas-
FIGURE 6 Dependence of D2O-ESEEM amplitudes on position, n, in the
sn-2 chain for spin-labeled phosphatidylcholine (n-PCSL) in DPPC bilayers.
Data (open circles) from Erilov et al. (18) are standardized according to Eqs.
1 and 2, and are fitted with a trough-like Boltzmann sigmoid (dotted line)
according to Marsh (10). Horizontal lines are the corresponding D2O-ampli-
tudes for 1:100 mol/mol TOACm-Alm analogs in DOPC (solid lines)
and DMPC (dashed lines) bilayers, as indicated. The value for TOAC16-
Alm in DMPC lies along the baseline.sembled channel complex, as compared with the peptide
monomer in fluid bilayers.
The alamethicin hydration profile in the saturated lipid
DMPC (Fig. 6, dashed lines) correlates neither with that in
the frozen unsaturated lipid DOPC nor with the polarity
sensed at the different TOAC positions in fluid lipid
membranes (Fig. 4). The highest water accessibility at the
TOAC8 position is consistent with a surface or interfacial
location, as suggested from the orientation results with
aligned membranes of saturated lipids in the gel phase
(Fig. 1). However, the D2O-ESEEM amplitude of TOAC
8-
Alm in DMPC, although greater than that at the TOAC8
position in DOPC, is less than that of TOAC1-Alm in the
unsaturated DOPC lipid. The reason for this, in addition to
the different orientation relative to the membrane normal,
is probably a combination of partial embedding in the
membrane and limited aggregation of the peptide.
The D2O-ESEEM amplitude at the TOAC
1 position in
DMPC, although smaller than that at the TOAC8 position,
is of a similar magnitude. On the other hand, the amplitude
at the TOAC16 position is much smaller, practically zero.
This difference can be understood from the relative orienta-
tions of the residue positions about the long axis of the alame-
thicin molecule. Fig. 7 shows one of the molecules in the
crystal structure of native alamethicin (36) to which the
predominant crystal conformer of the TOAC residue has
been grafted at position 1, 8, or 16 (8). The view is down
the axis of the longer (N-terminal) helix. It is seen that
TOAC1 and TOAC8 are situated on the same face of the mole-
cule in the N-terminal helix, whereas TOAC16, which resides
in the shorter C-terminal helix after Pro14, faces in a different
direction. Thus, TOAC1 and TOAC8 are likely to have more
similar locations in surface aggregates than does TOAC16,
which might penetrate rather deeper into the membrane and
be involved in peptide-peptide contacts that more efficiently
exclude water.
Hydrogen-bonded water
It is possible to use previous calibrations of D2O-ESEEM
intensities to give further information on the association ofFIGURE 7 Crystal structure for molecule A of native ala-
methicin ((36); PDB: 1amt) with the TOAC structure from
molecule B of Z-TOAC-(L-Ala)2-NHtBu (45) substituted
for Aib at residue position 1, 8, or 16 (8). The alamethicin
molecule is oriented with the axis of the longer helix perpen-
dicular to the plane of the figure and the N-terminus faces
upward from the plane of the figure.Biophysical Journal 96(3) 997–1007
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tative than the comparisons made above. Density functional
(DFT) calculations predict that the normalized 2H-ESEEM
intensity for one D2O molecule hydrogen bonded to the nitro-
xide is Ioz 115 ns (18). Thus, from the intensities of the broad
D2O-ESEEM components given in Table 1, it can be esti-
mated, for example, that the fraction of TOAC1-Alm
nitroxides that are hydrogen bonded to water is ~0.20 in
DOPC and 0.04 in DMPC, at a peptide/lipid ratio of 1:100
mol/mol. Further, the product of the equilibrium constant,
K, for hydrogen bonding and the effective concentration of





2  Ibroad=Io; (3)
where Ibroad is the normalized intensity of the broad D2O-
ESEEM component. This yields values of K[W] ¼ 0.11 and
0.02 for TOAC1-Alm in DOPC and DMPC, respectively.
Correspondingly, the fraction of TOAC that is hydrogen
bonded by a single water molecule is given by (18):
f1W ¼ 2
1=K½W þ 2 þ K½W (4)
that yields f1W z 0.18 and 0.04 for TOAC
1-Alm in DOPC
and DMPC, respectively. The fraction of TOAC that is









that yields f2Wz 0.01 and 0.0005 for TOAC
1-Alm in DOPC
and DMPC, respectively.
Table 4 summarizes the values of K[W], f1W, and f2W that
are obtained for all three TOAC positions in the two lipid
hosts. For comparison, the values that are obtained from
ESEEM with spin-labeled lipids in DPPC bilayers are:
K[W] ¼ 0.12 and 0.02, with fractions of nitroxides hydrogen
bonding to one water of f1W ¼ 0.20 and 0.04, and fractions
hydrogen bonding to two waters of f2W ¼ 0.01 and 0.00, at
chain positions C4 and C14, respectively, where the transition
TABLE 4 Fractions of TOACm-Alm hydrogen bonded by one
(f1W) and two (f2W) water molecules, and product of the
equilibrium constant for H-bonding, K, with the effective free
water concentration, [W], from 2H-ESEEM spectra of D2O-lipid
dispersions
Lipid/TOACm Peptide/lipid (mol/mol) K[W] f1W f2W
DMPC/TOAC1 1:275 0.04 0.08 0.002
1:100 0.02 0.04 0.0005
DMPC/TOAC8 1:275 0.07 0.12 0.004
1:100 0.06 0.10 0.003
DMPC/TOAC16 1:275,100 — 0 —
DOPC/TOAC1 1:100 0.11 0.18 0.01
DOPC/TOAC8 1:100 0.01 0.02 0.0
DOPC/TOAC16 1:100 0.005 0.01 0.0
Values deduced from Eqs. 3–5.Biophysical Journal 96(3) 997–1007between these two regions takes place at chain positions C10
to C12 (18). As for overall hydration, there is a clear distinc-
tion in the positional profiles of water hydrogen-bonded to the
TOAC residues between the unsaturated and saturated lipid
hosts. In unsaturated DOPC, there is appreciable hydrogen
bonding to TOAC1 with levels comparable to those at the
top of the lipid chains in peptide-free bilayers. There is little
water hydrogen bonded to TOAC8 and TOAC16, however,
in the case of DOPC. In the saturated DMPC lipid, water is
hydrogen bonded to both TOAC8 and TOAC1 and at levels
for the former that approach those for TOAC1 in the unsatu-
rated DOPC lipid. Neither configuration approaches levels
that might be expected for a large water-filled channel (for
which the total fractional population of spin label H-bonded
by water is f1W þ 2f2W ~ 0.8 (19)), possibly in part because
of orientational restrictions on optimum hydrogen bonding
and also none of the TOAC side chains may be directed
optimally into the channel lumen (cf. Fig. 7).
CONCLUSIONS
In conclusion, alamethicin associates differently with gel-
and fluid-phase lipids at near-ambient temperatures, and
with saturated and unsaturated lipids at low (cryogenic)
temperatures. Aligned membranes at ambient temperatures
indicate a transmembrane orientation of alamethicin in fluid
phase lipids, but an orientation more parallel to the
membrane surface in the gel phase. Water contact monitored
by D2O-ESEEM at low temperature indicates a transmem-
brane location for alamethicin in unsaturated lipids
(DOPC), but a more superficial location in saturated lipids
(DMPC). Spin-spin interaction, monitored from ED-spectra,
indicates a greater tendency to form specific oligomers for
the transmembrane orientation of alamethicin in DOPC
than for the more superficial location in DMPC. None of
the TOAC1, TOAC8 and TOAC16 residue positions experi-
ence the maximum degree of water contact that can be ex-
pected at the center of a large water-filled channel. However,
orientational restrictions make such a high degree of expo-
sure unlikely.
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